A Randomized, Placebo-Controlled Study Investigating the Impact of α-pinene on Symptom Relief, Quality of Life and Inflammatory Markers in Individuals with Ulcerative Colitis
Open Access
- 27 February 2025
- journal article
- Published by Brieflands in Jundishapur Journal of Natural Pharmaceutical Products
- Vol. 20 (1)
Abstract
Background: Given the limited evidence on the efficacy of α-pinene, a herbal terpenoid, in the management of ulcerative colitis (UC), this clinical trial aims to investigate the effects of α-pinene compared to a placebo. Methods: Eligible UC patients were randomized to receive either α-pinene or a placebo, alongside their routine pharmacologic regimen, for two months. Quality of life (QoL) and disease severity were assessed using the Simple Clinical Colitis Activity Index Questionnaire (SCCAIQ) and the Crohn’s and UC Questionnaire-8 (CUCQ-8), respectively. Additionally, erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) levels were measured as inflammatory markers. Results: The QoL was significantly improved in the α-pinene group compared to the placebo group (P = 0.02). Several items of the CUCQ-8 also showed better outcomes in the α-pinene group. However, there were no significant differences in ESR and CRP levels between the two groups (P = 0.64 and P = 0.78, respectively). Conclusions: α-pinene may be considered as a dietary supplement to enhance QoL and alleviate several symptoms in patients with UC.Keywords
This publication has 23 references indexed in Scilit:
- Effects of Pistacia genus on gastrointestinal tract disorders: A systematic and comprehensive reviewFitoterapia, 2024
- The effects of alpha-pinene on inflammatory responses and oxidative stress in the formalin testBrain Research Bulletin, 2023
- Ulcerative Colitis in AdultsJAMA, 2023
- Beneficial role of Pistacia lentiscus aqueous extract in experimental colitis: anti-inflammatory and potential therapeutic effectsInflammopharmacology, 2021
- Linking the IL-17A immune response with NMR-based faecal metabolic profile in IBD patients treated with MastihaBiomedicine & Pharmacotherapy, 2021
- Corrigendum: Development of a Short Questionnaire to Assess the Quality of Life in Crohn’s Disease and Ulcerative ColitisJournal of Crohn's and Colitis, 2019
- Plasma free amino acid profile in quiescent Inflammatory Bowel Disease patients orally administered with Mastiha (Pistacia lentiscus); a randomised clinical trialPhytomedicine, 2018
- A Review of Activity Indices and Efficacy End Points for Clinical Trials of Medical Therapy in Adults With Ulcerative ColitisGastroenterology, 2007
- Chemical composition of the essential oils from the gum and from various parts of Pistacia lentiscus l. (mastic gum tree)Flavour and Fragrance Journal, 1991
- A new measure of health status for clinical trials in inflammatory bowel diseaseGastroenterology, 1989